Board of Procter & Gamble Health recommends final dividend
30 - May - 2025 12:00 | 2 days ago
Procter & Gamble Health announced that the Board of Directors of the Company at its meeting held on 29 May 2025, inter alia, have recommended the final dividend of Rs 45 per equity Share (i.e. 450%) , subject to the approval of the shareholders.
Procter & Gamble Health standalone net profit rises 31.40% in the March 2025 quarter
30 - May - 2025 12:00 | 2 days ago
Net profit of Procter & Gamble Health rose 31.40% to Rs 61.18 crore in the quarter ended March 2025 as against Rs 46.56 crore during the previous quarter ended March 2024. Sales rose 23.17% to Rs 310.99 crore in the quarter ended March 2025 as against Rs 252.48 crore during the previous quarter ended March 2024.
Procter & Gamble Health standalone net profit rises 31.40% in the March 2025 quarter
30 - May - 2025 12:00 | 2 days ago
Net profit of Procter & Gamble Health rose 31.40% to Rs 61.18 crore in the quarter ended March 2025 as against Rs 46.56 crore during the previous quarter ended March 2024. Sales rose 23.17% to Rs 310.99 crore in the quarter ended March 2025 as against Rs 252.48 crore during the previous quarter ended March 2024.
Procter & Gamble Health standalone net profit rises 26.13% in the December 2024 quarter
12 - Feb - 2025 12:00 | 109 days ago
Net profit of Procter & Gamble Health rose 26.13% to Rs 90.90 crore in the quarter ended December 2024 as against Rs 72.07 crore during the previous quarter ended December 2023. Sales declined 0.06% to Rs 309.77 crore in the quarter ended December 2024 as against Rs 309.97 crore during the previous quarter ended December 2023.
Board of Procter & Gamble Health recommends final dividend
30 - May - 2025 12:00 | 2 days ago
Procter & Gamble Health announced that the Board of Directors of the Company at its meeting held on 29 May 2025, inter alia, have recommended the final dividend of Rs 45 per equity Share (i.e. 450%) , subject to the approval of the shareholders.
Procter & Gamble Health standalone net profit rises 31.40% in the March 2025 quarter
30 - May - 2025 12:00 | 2 days ago
Net profit of Procter & Gamble Health rose 31.40% to Rs 61.18 crore in the quarter ended March 2025 as against Rs 46.56 crore during the previous quarter ended March 2024. Sales rose 23.17% to Rs 310.99 crore in the quarter ended March 2025 as against Rs 252.48 crore during the previous quarter ended March 2024.
Procter & Gamble Health standalone net profit rises 26.13% in the December 2024 quarter
12 - Feb - 2025 12:00 | 109 days ago
Net profit of Procter & Gamble Health rose 26.13% to Rs 90.90 crore in the quarter ended December 2024 as against Rs 72.07 crore during the previous quarter ended December 2023. Sales declined 0.06% to Rs 309.77 crore in the quarter ended December 2024 as against Rs 309.97 crore during the previous quarter ended December 2023.
Board of Procter & Gamble Health recommends final dividend
30 - May - 2025 12:00 | 2 days ago
Procter & Gamble Health announced that the Board of Directors of the Company at its meeting held on 29 May 2025, inter alia, have recommended the final dividend of Rs 45 per equity Share (i.e. 450%) , subject to the approval of the shareholders.
Procter & Gamble Health standalone net profit rises 31.40% in the March 2025 quarter
30 - May - 2025 12:00 | 2 days ago
Net profit of Procter & Gamble Health rose 31.40% to Rs 61.18 crore in the quarter ended March 2025 as against Rs 46.56 crore during the previous quarter ended March 2024. Sales rose 23.17% to Rs 310.99 crore in the quarter ended March 2025 as against Rs 252.48 crore during the previous quarter ended March 2024.
Procter & Gamble Health standalone net profit rises 31.40% in the March 2025 quarter
30 - May - 2025 12:00 | 2 days ago
Net profit of Procter & Gamble Health rose 31.40% to Rs 61.18 crore in the quarter ended March 2025 as against Rs 46.56 crore during the previous quarter ended March 2024. Sales rose 23.17% to Rs 310.99 crore in the quarter ended March 2025 as against Rs 252.48 crore during the previous quarter ended March 2024.
Procter & Gamble Health standalone net profit rises 26.13% in the December 2024 quarter
12 - Feb - 2025 12:00 | 109 days ago
Net profit of Procter & Gamble Health rose 26.13% to Rs 90.90 crore in the quarter ended December 2024 as against Rs 72.07 crore during the previous quarter ended December 2023. Sales declined 0.06% to Rs 309.77 crore in the quarter ended December 2024 as against Rs 309.97 crore during the previous quarter ended December 2023.